Volker M. Lauschke

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

Catherine C. Bell, Delilah Hendriks, Sabrina Moro et al. · Scientific Reports · 2016 · 708 citations · Full text

Medicine, Pharmacology, Toxicology +17

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study

Catherine C. Bell, Anita C. A. Dankers, Volker M. Lauschke et al. · Toxicological Sciences · 2018 · 315 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono et al. · EMBO Molecular Medicine · 2020 · 272 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response

Mikael Kozyra, Magnus Ingelman‐Sundberg, Volker M. Lauschke · Genetics in Medicine · 2016 · 235 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17